Division of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
Division of Cardiac Surgery, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada.
Am J Cardiol. 2014 Aug 1;114(3):395-400. doi: 10.1016/j.amjcard.2014.04.051. Epub 2014 May 16.
People of South Asian (SA) descent are particularly susceptible to acute coronary syndromes (ACS). Yet, little information exists regarding their overall prognosis. The purpose of this study was to compare short- and long-term clinical outcomes of SA and European Canadians admitted with an ACS. Using the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease registry, 63,393 patients with ACS were reviewed (January 1999 to March 2012). After excluding Chinese patients, 1,825 SAs were compared with 60,791 European Canadians. Both groups were propensity matched, and outcomes were compared. Adjustment was performed using a 3:1 propensity matching technique. Adjusted 30-day and 1-year mortality rates were similar between SA and European patients with ACS (2.6% vs 2.7%, p = 0.93; 5.0% vs 4.8%, respectively, p = 0.75). Repeat angiography did not differ (9.9% vs 9.2%, p = 0.35), yet repeat revascularization within 1 year was greater in SA patients (9.8% vs 7.6%, p <0.01). Improved long-term survival (median 64 months, interquartile range 66 months) was noted with SA patients (hazard ratio [HR] 0.82, 95% confidence interval [CI] 0.71 to 0.95). In particular, long-term survival was observed in SA patients receiving coronary artery bypass grafting (HR 0.75, 95% CI 0.52 to 1.08) and percutaneous coronary intervention (HR 0.75, 95% CI 0.59 to 0.96). In conclusion, SA patients treated with revascularization appear to have improved long-term survival after ACS, compared with European Canadians. As such, clinicians should be cognitive of ethnic-based outcomes when determining therapeutic strategies in patient management.
南亚裔(SA)人群特别容易发生急性冠状动脉综合征(ACS)。然而,关于他们整体预后的信息很少。本研究的目的是比较患有 ACS 的 SA 和欧洲裔加拿大患者的短期和长期临床结局。使用艾伯塔省冠心病预后评估项目(APOPCA)注册中心,回顾了 63393 例 ACS 患者(1999 年 1 月至 2012 年 3 月)。排除中国患者后,比较了 1825 名 SA 患者和 60791 名欧洲裔加拿大患者。两组均采用倾向评分匹配,比较结局。采用 3:1 倾向评分匹配技术进行调整。调整后的 30 天和 1 年死亡率在 SA 和欧洲 ACS 患者之间相似(分别为 2.6%和 2.7%,p=0.93;5.0%和 4.8%,p=0.75)。重复血管造影术无差异(9.9%和 9.2%,p=0.35),但 1 年内再次血运重建在 SA 患者中更为常见(9.8%和 7.6%,p<0.01)。SA 患者的长期生存得到改善(中位 64 个月,四分位距 66 个月)(风险比[HR]0.82,95%置信区间[CI]0.71 至 0.95)。特别是,接受冠状动脉旁路移植术(HR 0.75,95%CI 0.52 至 1.08)和经皮冠状动脉介入治疗(HR 0.75,95%CI 0.59 至 0.96)的 SA 患者长期生存。结论:与欧洲裔加拿大患者相比,接受血运重建治疗的 SA 患者 ACS 后长期生存得到改善。因此,临床医生在确定患者管理中的治疗策略时,应考虑基于种族的结局。